Dupilumab, Pimecrolimus Lead in Pediatric AD Network Meta-Analysis
A Frontiers network meta-analysis ranks dupilumab and pimecrolimus as the most effective pediatric atopic dermatitis treatments for SCORAD and EASI improvement, pooling trials to compare therapies he…